BACKGROUND: Clinical experience with adenovirus vectors has highlighted the need for improved delivery and targeting. OBJECTIVE: This manuscript aims to provide an overview of the techniques currently under development for improving adenovirus delivery to malignant cells in vivo. METHODS: Primary research articles reporting improvements in adenoviral gene delivery are described. Strategies include genetic modification of viral coat proteins, non-genetic modifications including polymer encapsulation approaches and pharmacological interventions. RESULTS/ CONCLUSION: Reprogramming adenovirus tropism in vitro has been convincingly demonstrated using a range of genetic and physical strategies. These studies have provided new insights into our understanding of virology and the field is progressing. However, there are still some limitations that need special consideration before adenovirus-targeted cancer gene therapy emerges as a routine treatment in the clinical setting.
BACKGROUND: Clinical experience with adenovirus vectors has highlighted the need for improved delivery and targeting. OBJECTIVE: This manuscript aims to provide an overview of the techniques currently under development for improving adenovirus delivery to malignant cells in vivo. METHODS: Primary research articles reporting improvements in adenoviral gene delivery are described. Strategies include genetic modification of viral coat proteins, non-genetic modifications including polymer encapsulation approaches and pharmacological interventions. RESULTS/ CONCLUSION: Reprogramming adenovirus tropism in vitro has been convincingly demonstrated using a range of genetic and physical strategies. These studies have provided new insights into our understanding of virology and the field is progressing. However, there are still some limitations that need special consideration before adenovirus-targeted cancer gene therapy emerges as a routine treatment in the clinical setting.
Authors: Pablo Guardado-Calvo; Antonio L Llamas-Saiz; Gavin C Fox; Joel N Glasgow; Mark J van Raaij Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun Date: 2009-10-30
Authors: Anil Vachani; Edmund Moon; Elliot Wakeam; Andrew R Haas; Daniel H Sterman; Steven M Albelda Journal: Clin Chest Med Date: 2011-10-07 Impact factor: 2.878
Authors: Pablo Guardado-Calvo; Eva M Muñoz; Antonio L Llamas-Saiz; Gavin C Fox; Richard Kahn; David T Curiel; Joel N Glasgow; Mark J van Raaij Journal: J Virol Date: 2010-08-04 Impact factor: 5.103
Authors: Ilkka Liikanen; Vladia Monsurrò; Laura Ahtiainen; Mari Raki; Tanja Hakkarainen; Iulia Diaconu; Sophie Escutenaire; Otto Hemminki; João D Dias; Vincenzo Cerullo; Anna Kanerva; Sari Pesonen; Daniela Marzioni; Marco Colombatti; Akseli Hemminki Journal: Mol Ther Date: 2011-07-26 Impact factor: 11.454
Authors: Vladia Monsurrò; Stefania Beghelli; Richard Wang; Stefano Barbi; Silvia Coin; Giovanni Di Pasquale; Samantha Bersani; Monica Castellucci; Claudio Sorio; Stefano Eleuteri; Andrea Worschech; Jay A Chiorini; Paolo Pederzoli; Harvey Alter; Francesco M Marincola; Aldo Scarpa Journal: J Transl Med Date: 2010-01-29 Impact factor: 5.531